About The Medical Condition Clinical Trial, Phase II (PT)

ClusterMed

Find the definition of the medical term Clinical Trial, Phase II (PT). Clinical Trial, Phase II (PT) defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

Clinical Trial, Phase II (PT)

Clinical Trial, Phase II (PT) Medical Condition Defined & Explained
Clinical Trial, Phase II (PT) Medical Condition

What's The Definition Of The Medical Condition Clinical Trial, Phase II (PT)?

A pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on several hundred volunteers, including a limited number of patients, and conducted over a period of about two years in either the United States or a foreign country.

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day

  • Woman Rights ‐ The rights of women to equal status pertaining to social, economic,…
  • Neurotheceomas ‐ A benign myxoma of cutaneous nerve sheath origin. Theke is from…
  • Atrial Natriuretic Factor Receptors ‐ Cell surface proteins that bind atrial natriuretic factor with…
  • Estrone, (+-)-Isomer ‐ A metabolite of estradiol but possessing less biological activity.…
  • Television ‐ The transmission and reproduction of transient images of fixed…
  • Abnormalities, Musculoskeletal ‐ Congenital structural abnormalities and deformities of the musculoskeletal…
  • Juvenile Periodontitis ‐ Localized periodontitis in teenagers and young adults. The onset…
  • Mammoplasties ‐ Surgical reconstruction of the breast including both augmentation…
  • Gamma-Tocopherol ‐ A natural tocopherol with less antioxidant activity than ALPHA-TOCOPHEROL.…
  • PGE1 ‐ A potent vasodilator agent that increases peripheral blood flow.…